Summit Science

Researchers seeking a link between vision problems and the dangerous physiological effects of hypoxia in mountain climbers are taking their work to new heights.

Written byAlison Snyder
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Last June, 28-year-old British climber Peter Kinloch achieved his lifelong goal of summiting Mount Everest. But on the descent, something went wrong. Kinloch began stumbling and slipping, went blind, and could not continue down the mountain. Medicating and oxygenating him proved unsuccessful, and with the weather worsening, the Sherpas guiding Kinloch had to leave him to die at 8,600 meters.

Mountaineers often report compromised vision at high altitudes where oxygen is scarce, and this problem can occur in concert with a suite of other symptoms that spell real trouble for someone traversing precarious trails thousands of meters up jagged peaks. But the link between hypoxic conditions, acute mountain sickness (AMS), and vision is poorly understood.

According to ophthalmologist Gabriel Willmann, if changes in the eye are linked to AMS—symptoms of which are nausea, headaches, fatigue, and dizziness—it may be possible to develop a diagnostic test that could save the lives ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies